HUP0301649A3 - Process for preparing azacycloalkanoylaminothiazoles - Google Patents
Process for preparing azacycloalkanoylaminothiazolesInfo
- Publication number
- HUP0301649A3 HUP0301649A3 HU0301649A HUP0301649A HUP0301649A3 HU P0301649 A3 HUP0301649 A3 HU P0301649A3 HU 0301649 A HU0301649 A HU 0301649A HU P0301649 A HUP0301649 A HU P0301649A HU P0301649 A3 HUP0301649 A3 HU P0301649A3
- Authority
- HU
- Hungary
- Prior art keywords
- azacycloalkanoylaminothiazoles
- preparing
- preparing azacycloalkanoylaminothiazoles
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61662700A | 2000-07-26 | 2000-07-26 | |
| US09/746,060 US6414156B2 (en) | 1998-10-21 | 2000-12-22 | Process for preparing azacycloalkanoylaminothiazoles |
| PCT/US2001/014155 WO2002010163A1 (en) | 2000-07-26 | 2001-05-02 | Process for preparing azacycloalkanoylaminothiazoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0301649A2 HUP0301649A2 (hu) | 2003-12-29 |
| HUP0301649A3 true HUP0301649A3 (en) | 2008-04-28 |
Family
ID=27087817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0301649A HUP0301649A3 (en) | 2000-07-26 | 2001-05-02 | Process for preparing azacycloalkanoylaminothiazoles |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US6414156B2 (hu) |
| EP (1) | EP1303514B9 (hu) |
| JP (1) | JP2004505080A (hu) |
| KR (1) | KR100764949B1 (hu) |
| CN (1) | CN1227250C (hu) |
| AT (1) | ATE299878T1 (hu) |
| AU (1) | AU5936901A (hu) |
| BR (1) | BR0112748A (hu) |
| CA (1) | CA2417260A1 (hu) |
| CY (1) | CY1105666T1 (hu) |
| CZ (1) | CZ2003239A3 (hu) |
| DE (1) | DE60112091T2 (hu) |
| DK (1) | DK1303514T3 (hu) |
| ES (1) | ES2245984T3 (hu) |
| HK (1) | HK1052928A1 (hu) |
| HU (1) | HUP0301649A3 (hu) |
| IL (2) | IL153748A0 (hu) |
| LT (1) | LT5106B (hu) |
| MX (1) | MXPA03000685A (hu) |
| PL (1) | PL365464A1 (hu) |
| PT (1) | PT1303514E (hu) |
| WO (1) | WO2002010163A1 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6414156B2 (en) | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
| US6392053B2 (en) | 1999-12-15 | 2002-05-21 | Bristol-Myers Squibb Company | Process for preparing arylacetylaminothiazoles |
| US6534531B2 (en) * | 2000-04-27 | 2003-03-18 | Bristol-Myers Squibb Company | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| CN100457753C (zh) * | 2000-07-26 | 2009-02-04 | 布里斯托尔-迈尔斯斯奎布公司 | 依赖细胞周期蛋白的激酶的n－[5－[[[5－烷基－2－唑基]甲基]硫代]－2－噻唑基]甲酰胺抑制剂 |
| DE10300124A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Verfahren zur Herstellung von Arylalkinen |
| US7601725B2 (en) * | 2004-07-16 | 2009-10-13 | Sunesis Pharmaceuticals, Inc. | Thienopyrimidines useful as Aurora kinase inhibitors |
| EP2044066A2 (en) * | 2006-06-06 | 2009-04-08 | Bristol-Myers Squibb Company | Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
| TW200922564A (en) * | 2007-09-10 | 2009-06-01 | Curis Inc | CDK inhibitors containing a zinc binding moiety |
| WO2010075542A1 (en) | 2008-12-23 | 2010-07-01 | Curis, Inc. | Cdk inhibitors |
| EP3384897A1 (de) * | 2017-04-03 | 2018-10-10 | Covestro Deutschland AG | Kosmetische zusammensetzungen mit speziellen carbodiimiden für haare |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1088049A (en) | 1975-06-03 | 1980-10-21 | Takashi Masugi | 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof |
| CA1201431A (en) | 1981-12-17 | 1986-03-04 | Daiei Tunemoto | .beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF |
| NO831160L (no) | 1982-04-08 | 1983-10-10 | Erba Farmitalia | Fremstilling av substituerte penem-derivater |
| JPS6339868A (ja) | 1986-08-04 | 1988-02-20 | Otsuka Pharmaceut Factory Inc | ジ低級アルキルフエノ−ル誘導体 |
| TW205041B (hu) | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
| DE4119756A1 (de) | 1991-06-15 | 1992-12-17 | Basf Ag | Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung |
| US5491157A (en) | 1993-05-10 | 1996-02-13 | Eastman Kodak Company | Method and composition for the prevention, control and amelioration of soilborne fungi and disease caused thereby |
| IL112721A0 (en) | 1994-03-10 | 1995-05-26 | Zeneca Ltd | Azole derivatives |
| JPH0859669A (ja) | 1994-06-13 | 1996-03-05 | Takeda Chem Ind Ltd | セフェム化合物、その製造法及び剤 |
| JPH10510258A (ja) | 1994-12-09 | 1998-10-06 | 藤沢薬品工業株式会社 | セフェム化合物およびその医薬用途 |
| IL117620A0 (en) | 1995-03-27 | 1996-07-23 | Fujisawa Pharmaceutical Co | Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same |
| AUPN801196A0 (en) | 1996-02-12 | 1996-03-07 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds and pharmaceutical use thereof |
| YU22400A (sh) | 1997-10-27 | 2003-08-29 | Agouron Pharmaceuticals Inc. | Supstituisana 4-amino-tiazol-2-i jedinjenja kao cdks inhibitori |
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6040321A (en) * | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6214852B1 (en) | 1998-10-21 | 2001-04-10 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| US6414156B2 (en) | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
| GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
| MY125768A (en) | 1999-12-15 | 2006-08-30 | Bristol Myers Squibb Co | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| US6534531B2 (en) | 2000-04-27 | 2003-03-18 | Bristol-Myers Squibb Company | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| CN100457753C (zh) | 2000-07-26 | 2009-02-04 | 布里斯托尔-迈尔斯斯奎布公司 | 依赖细胞周期蛋白的激酶的n－[5－[[[5－烷基－2－唑基]甲基]硫代]－2－噻唑基]甲酰胺抑制剂 |
-
2000
- 2000-12-22 US US09/746,060 patent/US6414156B2/en not_active Expired - Lifetime
-
2001
- 2001-05-02 CA CA002417260A patent/CA2417260A1/en not_active Abandoned
- 2001-05-02 AT AT01932879T patent/ATE299878T1/de not_active IP Right Cessation
- 2001-05-02 DK DK01932879T patent/DK1303514T3/da active
- 2001-05-02 DE DE60112091T patent/DE60112091T2/de not_active Expired - Fee Related
- 2001-05-02 PL PL01365464A patent/PL365464A1/xx not_active Application Discontinuation
- 2001-05-02 AU AU5936901A patent/AU5936901A/xx active Pending
- 2001-05-02 JP JP2002515892A patent/JP2004505080A/ja not_active Withdrawn
- 2001-05-02 PT PT01932879T patent/PT1303514E/pt unknown
- 2001-05-02 WO PCT/US2001/014155 patent/WO2002010163A1/en active IP Right Grant
- 2001-05-02 HU HU0301649A patent/HUP0301649A3/hu unknown
- 2001-05-02 KR KR1020037001143A patent/KR100764949B1/ko not_active IP Right Cessation
- 2001-05-02 EP EP01932879A patent/EP1303514B9/en not_active Expired - Lifetime
- 2001-05-02 IL IL15374801A patent/IL153748A0/xx unknown
- 2001-05-02 ES ES01932879T patent/ES2245984T3/es not_active Expired - Lifetime
- 2001-05-02 CZ CZ2003239A patent/CZ2003239A3/cs unknown
- 2001-05-02 BR BR0112748-9A patent/BR0112748A/pt not_active Application Discontinuation
- 2001-05-02 CN CNB018131786A patent/CN1227250C/zh not_active Expired - Fee Related
- 2001-05-02 MX MXPA03000685A patent/MXPA03000685A/es active IP Right Grant
-
2002
- 2002-03-18 US US10/100,129 patent/US6639074B2/en not_active Expired - Lifetime
- 2002-12-30 IL IL153748A patent/IL153748A/en not_active IP Right Cessation
-
2003
- 2003-01-07 LT LT2003001A patent/LT5106B/lt not_active IP Right Cessation
- 2003-05-13 HK HK03103394A patent/HK1052928A1/xx not_active IP Right Cessation
- 2003-08-12 US US10/639,272 patent/US6897321B2/en not_active Expired - Lifetime
-
2005
- 2005-09-02 CY CY20051101065T patent/CY1105666T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG23914A (en) | Process for preparing an antichnolinergic | |
| CZ20023563A3 (cs) | Způsob přípravy 2-halogenbenzoových kyselin | |
| GB0011120D0 (en) | Process | |
| GB0028179D0 (en) | Process for preparing pouches | |
| HUP0104566A3 (en) | Process for producing n-carboxi-anhidrides | |
| HK1049327A1 (zh) | 製備氨基二苯基胺的方法 | |
| HUP0300160A3 (en) | Process for preparing (+)-cis-sertraline | |
| GB0013793D0 (en) | Process | |
| HUP0104405A3 (en) | Process for preparing imidachlopid | |
| GB0010437D0 (en) | Process | |
| HUP0301649A3 (en) | Process for preparing azacycloalkanoylaminothiazoles | |
| HUP0300114A3 (en) | Process for preparing flavonoid-derivatives | |
| GB0002201D0 (en) | Process | |
| AU4663601A (en) | Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin | |
| HUP0000559A3 (en) | Process for preparing cyanoaceticacidesters | |
| IL143395A0 (en) | Process for preparing alkyl- or aryloxyacetaldehydes | |
| GB0013791D0 (en) | Process | |
| AU8444201A (en) | Process for producing fluoroalkanol | |
| AU2002228593A8 (en) | Process for preparing alpha-(3-arylthio)-acetophenones | |
| HU0204443D0 (en) | Process for preparing fluoroformates | |
| AU2001261564A1 (en) | Process for preparing cis-aminochromanols | |
| GB0001564D0 (en) | Process | |
| GB0006722D0 (en) | Process | |
| GB0024366D0 (en) | Process for preparing pouches | |
| AU2001286392A1 (en) | Process for preparing 2-phenyl-3-aminobenzothiophenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |